Pegylated liposomes have potential as vehicles for intratumoral and subcutaneous drug delivery

Clinical Cancer Research

Volumn 6, Issue 6, 2000, Pages 2528-2537

  Harrington, Kevin J ^a,b   Rowlinson Busza, Gail ^a   Syrigos, Konstantinos N ^a   Uster, Paul S ^c   Vile, Richard G ^b   Stewart, J Simon W ^d  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b MAYO CLINIC   (United States)

^c ALZA CORPORATION   (United States)

^d CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG VEHICLE; LIPOSOME; PENTETIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; FEMALE; HEAD AND NECK CANCER; INTRATUMORAL DRUG ADMINISTRATION; LYMPH NODE METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; AREA UNDER CURVE; CHELATING AGENTS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FEMALE; HEAD AND NECK NEOPLASMS; INJECTIONS, SUBCUTANEOUS; LIPOSOMES; LYMPH NODES; MICE; MICE, NUDE; PENTETIC ACID; POLYETHYLENE GLYCOLS; RADIATION-SENSITIZING AGENTS; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 0034045346     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Papahadjopoulos, D., Allen, T. M., Gabizon, A., Mayhew, E., Matthay, K., Huang, S. K., Lee, K. D., Woodle, M. C., Lasic, D. D., Redemann, C., and Martin, F. J. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc. Natl. Acad. Sci. USA, 88: 11460-11464, 1991.
2. Huang, S. K., Lee, K-D., Hong, K., Friend, D. S., and Papahadjopoulos, D. Microscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice. Cancer Res., 52: 5135-5143, 1992.
3. Huang, S. K., Martin, F. J., Jay, G., Vogel, J., Papahadjopoulos, D., and Friend, D. S. Extravasation and transcytosis of liposomes in Kaposi's sarcoma-like dermal lesions of transgenic mice bearing the HIV tat gene. Am. J. Pathol., 143: 1-14, 1993.
4. 111in-DTPA-labelled pegylated liposomes in a human tumor xenograft model: implications for novel targetting strategies. Br. J. Cancer, in press, 2000.
5. Harrington, K. J., Lewanski, C. R., and Stewart, J. S. W. Liposomes as vehicles for targeted therapy of cancer. Part 1: Preclinical development. Clin. Oncol. (R. Coll. Radiol.), 12: 2-15, 2000.
6. Stewart, J. S. W., Jablonowski, H., Goebel, F-D., Arasteh, K., Spittle, M., Rios, A., Aboulafia, D., Galleshaw, J., and Dezube, B. J. Randomised comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group. J. Clin. Oncol., 16: 683-691, 1998.
7. Northfelt, D. W., Dezube, B., Thommes, J. A., Miller, B. J., Fischl, M. A., Friedman-Kien, A., Kaplan, L. D., Dumond, C., Mamelok, R. D., and Henry, D. H. Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomised phase III clinical trial. J. Clin. Oncol., 16: 2445-2451, 1998.
8. Muggia, F. M., Hainsworth, J. D., Jeffers, S., Miller, P., Groshen, S., Tan, M., Roman, L., Uziely, B., Muderspach, L., Garcia, A., Burnett, A., Greco, F. A., Morrow, C. P., Paradise, L., and Liang, L-J. Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation. J. Clin. Oncol., 15: 987-993, 1997.
9. Ranson, M. R., Carmichael, J., O'Byrne, K., Stewart, S., Smith, D., and Howell, A. Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: results of a multicentre Phase II trial. J. Clin. Oncol., 15: 3185-3191, 1997.
10. Madhavan, S., and Northfelt, D. W. Lack of vesicant injury following extravasation of liposomal doxorubicin. J. Natl. Cancer Inst., 87: 1556-1557, 1995.
11. Mayhew, E., Cimino, M., Klemperer, J., Lazo, R., Wiernikowski, J., and Arbuck, S. Free and liposomal doxorubicin treatment of intraperitoneal colon 26 tumor: therapeutic and pharmacologic studies. Sel. Cancer Ther., 6: 193-209, 1990.
12. Perez-Soler, R., Lopez-Berestein, G., Lautersztain, J., Al-Baker, S., Francis, K., Macias-Kiger, D., Raber, M. N., and Khokhar, A. R. Phase I clinical and pharmacology study of liposome-entrapped cis-bis-neodecanoato trans-R,R-1,2 diaminocyclohexane platinum (II). Cancer Res., 50: 4254-4259, 1990.
13. Malik, S. T., Martin, D., Hart, I., and Balkwill, F. Therapy of human ovarian cancer xenografts with intraperitoneal liposome encapsulated muramyl-tripeptide phosphoethanolamine (MTP-PE) and recombinant GM-CSF. Br. J. Cancer, 63: 399-403, 1991.
14. Vadiei, K., Siddik, Z. H., Khokhar, A. R., Al-Baker, S., Sampedro, F., and Perez-Soler, R. Pharmacokinetics of liposome-entrapped cis-bis-neodecanoato trans-R,R-1,2 diaminocyclohexane platinum (II) and cis-platin given i.v. and i.p. in the rat. Cancer Chemother. Pharmacol., 30: 365-369, 1992.
15. Vaage, J., Donovan, D., Mayhew, E., Abra, R., and Huang, A. Therapy of human ovarian carcinoma xenografts using doxorubicin encapsulated in sterically stabilized liposomes. Cancer (Phila.), 72: 3671-3675, 1993.
16. Daoud, S. S. Combination chemotherapy of human ovarian xenografts with intraperitoneal liposome-incorporated valinomycin and cis-diamminedichloroplatinum (II). Cancer Chemother. Pharmacol., 33: 307-312, 1994.
17. Sharma, A., Mayhew, E., Bolcsak, L., Cavanaugh, C., Harmon, P., Janoff, A., and Bernacki, R. J. Activity of paclitaxel liposome formulations against human ovarian tumor xenografts. Int. J. Cancer, 71: 103-107, 1997.
18. Sharma, A., Sharma, U. S., and Straubinger, R. M. Paclitaxel-liposomes for intracavitary therapy of intraperitoneal P388 leukaemia. Cancer Lett., 107: 265-272, 1996.
19. Perez-Soler, R., Shin, D. M., Siddik, Z. H., Murphy, W. K., Huber, M., Lee, S. J., Khokhar, A. R., and Hong, W. K. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions. Clin. Cancer Res., 3: 373-379, 1997.
20. Kim, S., Kim, D. J., Geyer, M. A., and Howell, S. B. Multivesicular liposomes containing 1-β-D-arabinofuranosylcytosine for slow-release intrathecal therapy. Cancer Res., 47: 3935-3937, 1987.
21. Eagle, H. Propagation in a fluid medium of a human epidermoid carcinoma, strain KB. Proc. Soc. Exp. Biol. Med., 89: 362-364, 1955.
22. Rowlinson-Busza, G., Bamias, A., Krausz, T., and Epenetos, A. A. Uptake and distribution of specific and control monoclonal antibodies in subcutaneous xenografts following intratumor injection. Cancer Res., 51: 3251-3256, 1991.
23. Hopkins, K., Chandler, C., Bullimore, J., Sandeman, D., Coakham, H., and Kemshead, J. T. A pilot study of the treatment of patients with recurrent malignant gliomas with intratumoral yttrium-90 radioimmunoconjugates. Radiother. Oncol., 34: 121-131, 1995.
24. Borchardt, P. E., Quadri, S. M., Freedman, R. S., and Vriesendorp, H. M. Intralesional radiolabeled human monoclonal IgM in human tumor xenografts. Radiother. Oncol., 44: 283-293, 1997.
25. Ning, S., Trisler, K., Brown, D. M., Yu, N. Y., Kanekal, S., Lundsten, M. J., and Knox, S. J. Intratumoral radioimmunotherapy of a human colon cancer xenograft using a sustained-release gel. Radiother. Oncol., 39: 179-189, 1996.
26. Florence, A. T. Targeted therapy with microspheres and other carrier systems. In: M. Peckham, H. M. Pinedo, and U. Veronesi (eds.), Oxford Textbook of Oncology, Vol. 1. Oxford: Oxford University Press, 1995.
27. Rudolph, R., Stein, R. S., and Pattillo, R. A. Skin ulcers due to Adriamycin. Cancer (Phila.), 38: 1087-1094, 1976.
28. Loth, T. S., and Eversmann, W. W., Jr. Treatment methods for extravasation of chemotherapeutic agents: a comparative study. J. Hand Surg. Am., 11: 388-396, 1986.
29. Vaage, J., Barbera-Guillem, E., Abra, R., Huang, A., and Working, P. Tissue distribution and therapeutic effect of intravenous free or encapsulated liposomal doxorubicin on human prostate carcinoma xenografts. Cancer (Phila.), 73: 1478-1484, 1994.
30. Vaage, J., Donovan, D., Uster, P., and Working, P. Tumor uptake of doxorubicin in polyethylene glycol-coated liposomes and therapeutic effect against a xenografted human pancreatic carcinoma. Br. J. Cancer, 75: 482-486, 1997.
31. Harrington, K. J., Rowlinson-Busza, G., Uster, P. S., and Stewart, J. S. W. Pegylated liposome encapsulated doxorubicin and cisplatin in the treatment of head and neck xenograft tumours. Cancer Chemother. Pharmacol., in press, 2000.
32. Konno, H., Yamashita, A., Tadakuma, T., and Sakaguchi, S. Inhibition of growth of rat hepatoma by local injection of liposomes containing recombinant interleukin-2. Antitumor effect of IL-2 liposome. Biotherapy (Tokyo), 3: 211-218, 1991.
33. Bostick, P., Essner, R., Sarantou, T., Kelley, M., Glass, E., Foshag, L., Stern, S., and Morton, D. Intra-operative lymphatic mapping for early stage melanoma of the head and neck. Am. J. Surg., 174: 536-539, 1997.
34. Krag, D., Weaver, D., Ashikaga, T., Moffat, F., Klimberg, V. S., Shriver, C., Feldman, S., Kusminsky, R., Gadd, M., Kuhn, J., Harlow, S., and Beitsch, P. The sentinel node in breast cancer - a multicenter validation study. N. Engl. J. Med., 339: 941-946, 1998.
35. Lindberg, R. Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer (Phila.), 29: 1446-1449, 1972.
36. Suen, J. Y., and Goepfort, A. Standardisation of neck dissection nomenclature. Head Neck Surg., 10: 75-77, 1987.
37. Kirkwood, J. M., Strawderman, M. H., Ernstoff, M. S., Smith, T. J., Borden, E. C., and Blum, R. H. Interferon α-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J. Clin. Oncol., 14: 7-17, 1996.
38. Denis, L. J., Keuppens, F., Smith, P. H., Whelan, P., de Moura, J. L., Newling, D., Bono, A., and Sylvester, R. Maximal androgen blockade: final analysis of EORTC Phase III trial 30853. EORTC Genito-Urinary Tract Cancer Cooperative Group and the EORTC Data Center. Eur. Urol., 33: 144-151, 1998.
39. Naysmith, A. Palliative care. In: P. Price and K. Sikora, (eds.), Treatment of Cancer, Ed. 3, London: Chapman and Hall, 1995.
40. Saito, H., and Tomioka, H. Therapeutic efficacy of liposome-entrapped rifampicin against Mycobacterium avium complex infection induced in mice. Antimicrob. Agents Chemother., 33: 429-433, 1989.
41. Titulaer, H. A., Eling, W. M., Crommelin, D. J., Peeters, P. A., and Zuidema, J. The parenteral controlled release of liposome encapsulated chloroquine in mice. J. Pharm. Pharmacol., 42: 529-532, 1990.
42. Grayson, L. S., Hansborough, J. F., Zapata-Sirvent, R., Roehrborn, A. J., Kim, T., and Kim, S. Soft tissue infection prophylaxis with gentamicin encapsulated in multivesicular liposomes: results from a prospective, randomised trial. Crit. Care Med., 23: 84-91, 1995.
43. Roy, R., and Kim, S. Multivesicular liposomes containing bleomycin for subcutaneous administration. Cancer Chemother. Pharmacol., 28: 105-108, 1991.
44. Anderson, P. M., Katsanis, E., Sencer, S. F., Hasz, D., Ochoa, A. C., and Bostrom, B. Depot characteristics and biodistribution of interleukin-2 liposomes. J. Immunother., 12: 19-31, 1992.
45. Kaledin, V. I., Matienko, N. A., Nikolin, V. P., Gruntenko, Y. V., and Budker, V. G. Intralymphatic administration of liposome-encapsulated drugs to mice: possibility for suppression of the growth of tumor metastases in the lymph nodes. J. Natl. Cancer Inst., 66: 881-887, 1981.
46. Perez-Soler, R., Lopez-Berestein, G., Jahns, M., Wright, K., and Kasi, L. P. Distribution of radiolabelled multilamellar liposomes injected intralymphatically and subcutaneously. Int. J. Nucl. Med. Biol., 12: 261-266, 1985.
47. Perez-Soler, R., Lopez-Berestein, G., Kasi, L. P., Cabanillas, F., Jahns, M., Glenn, H., Hersh, E. M., and Haynie, T. Distribution of technetium-99m-labelled multilamellar liposomes in patients with Hodgkin's disease. J. Nucl. Med., 26: 743-749, 1985.
48. Allen, T. M., Hansen, C. B., and Guo, L. S. Subcutaneous administration of liposomes: a comparison with the intravenous and intraperitoneal routes of injection. Biochim. Biophys. Acta, 1150: 9-16, 1993.